BPC-157 is a synthetic chain of 15 amino acids copied from a fragment of a protein found in human gastric juice. Its name stands for Body Protection Compound. Over 30 years of research, mostly in rats, it has shown repeated effects on tendon, ligament, muscle, gut and blood-vessel repair, which is why people call it the “Wolverine peptide.”
The catch: almost all of that evidence is animal and cell work from a small number of labs. Controlled human trials are close to non-existent. BPC-157 is not an approved drug in Canada, the US or Europe, and it has been on the World Anti-Doping Agency’s prohibited list since 2022. Below is what it is, how it appears to work, what the evidence actually shows, and what to check before buying it for research.
What BPC-157 actually is
BPC-157 is a pentadecapeptide, a peptide made of 15 amino acids. Its sequence is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Written in one-letter code, that is GEPPPGKPADDAGLV, with a molecular weight of about 1,419 daltons. For comparison, insulin has 51 amino acids and growth hormone has 191, so BPC-157 is a small molecule by protein standards. That small size is one reason it is cheap to synthesize and one reason it has been easy for labs to study.
Three things set it apart from most research peptides:
- It is unusually stable. Most peptides break down quickly in stomach acid. BPC-157 was isolated from gastric juice in the first place, and animal studies report that it survives there, which is why researchers have tested it orally as well as by injection.
- It seems to act on many tissues at once. Instead of hitting one receptor, it appears to nudge several repair systems: blood-vessel growth, nitric oxide signalling, and growth-factor pathways in fibroblasts.
- It has no known natural receptor. Nobody has identified a single “BPC-157 receptor,” which makes its mechanism harder to pin down than a classic drug’s.
Where it came from
Almost everything we know about BPC-157 traces back to one group: Professor Predrag Sikiric and colleagues at the University of Zagreb in Croatia. In the early 1990s they described a protective protein in human gastric juice they called BPC, and then isolated a 15-amino-acid fragment of it that carried much of the activity. That fragment is BPC-157.
The original interest was the stomach. Their early work tested whether the peptide protected the stomach lining from damage by alcohol, NSAID painkillers and stress. Over the following decades the same group extended the work to tendons, ligaments, muscle, bone, blood vessels, the liver and the brain, publishing well over a hundred papers.
A large body of research that comes mostly from one lab is a yellow flag, not a red one. It does not mean the findings are wrong. It does mean they have not been independently reproduced at the scale you would want before calling anything proven. Keep that in mind every time you read “studies show BPC-157…”
Why it’s called the “Wolverine peptide”
The nickname comes from the Marvel character who heals from almost anything. It caught on in fitness and biohacking circles around 2018–2020, as podcast hosts and athletes began talking about BPC-157 for injuries that were slow to heal, especially tendons, which have a poor blood supply and are notoriously stubborn.
The nickname is marketing, not science. It describes what people hope the peptide does, based on rat studies where injured tendons and ligaments healed faster and stronger than in untreated animals. Whether that translates to people is exactly the open question.
How it appears to work
Researchers have proposed several mechanisms. None has been confirmed as “the” mechanism, and they probably overlap.
1. Building new blood vessels (angiogenesis)
Healing tissue needs blood flow. In cell and animal work, BPC-157 increased activation of VEGFR2, the main receptor for vascular endothelial growth factor, and promoted new blood-vessel formation (Hsieh et al., 2017). This is the most cited explanation for faster tendon and ligament repair, since those tissues are poorly vascularized to begin with.
2. Helping fibroblasts move and survive
Fibroblasts are the cells that lay down collagen and rebuild connective tissue. In a well-known study on rat tendon cells, BPC-157 increased tendon cell outgrowth, survival under stress and migration, through the FAK–paxillin pathway that controls how cells crawl into a wound (Chang et al., 2011).
3. Upregulating growth hormone receptors in tendon cells
A follow-up study from the same Taiwanese group found BPC-157 increased the number of growth hormone receptors on tendon fibroblasts, which could make the tissue more responsive to the body’s own growth signals (Chang et al., 2014).
4. Balancing the nitric oxide system
Many Sikiric papers describe BPC-157 as a modulator of nitric oxide (NO), the molecule that controls blood-vessel tone. In their models it counteracts both too much and too little NO activity, which they use to explain its effects on blood pressure, blood clots and the gut lining.
What the research shows, area by area
Tendons and ligaments
This is where BPC-157 has its reputation. In rats with surgically cut Achilles tendons or medial collateral ligaments, treated animals showed better functional recovery, more organized collagen and stronger repaired tissue than controls. Reviews of this literature conclude that the animal results are consistent and promising, but that human trials are missing (Gwyer et al., 2019). For more on recovery timelines in studies, see how long BPC-157 takes to work in research.
Muscle
Rat studies of crushed or torn muscle, including the quadriceps and gastrocnemius, report faster functional recovery. Some studies also report protection against muscle damage caused by corticosteroids.
Gut and stomach
The original research area. In animals, BPC-157 protected the stomach lining against alcohol and NSAIDs, sped healing of ulcers, and improved models of inflammatory bowel disease and fistulas. This is also the area where a human phase I trial was once planned (see below).
Bone
A smaller set of rat and rabbit studies reports faster healing of bone defects. The evidence here is thinner than for tendon.
Brain and nervous system
Animal studies have looked at nerve injury, models of traumatic brain injury, and interactions with dopamine and serotonin systems. These are early and mostly from the Zagreb group.
Blood vessels and organs
Papers describe effects on blood clots, blood pressure and liver injury in rodents. Interesting, but early.
The evidence scorecard
Here is an honest grading of where the research stands, from the strongest animal evidence to the weakest.
| Research area | Animal / cell evidence | Human evidence | Independent replication |
|---|---|---|---|
| Tendon & ligament | Strong, consistent | Very limited | Partial (Taiwan group) |
| Stomach & gut lining | Strong, consistent | None published | Limited |
| Muscle injury | Moderate | None | Limited |
| Bone healing | Moderate | None | Limited |
| Blood vessels / NO | Moderate | None | Limited |
| Brain & nerves | Early | None | Very limited |
The human evidence problem
This is the part most vendor pages skip. After three decades, the published human data on BPC-157 fit in a few lines:
- A retrospective knee-pain report (2021). A US clinic looked back at 16 patients with various kinds of knee pain who had received BPC-157 and reported that most said their pain improved (Lee & Padgett, 2021). There was no control group, no blinding and no standardized measurement, so it cannot tell us whether BPC-157 caused the improvement.
- A phase I safety trial that never reported. A small safety and pharmacokinetics trial was registered in 2015, aimed at eventually treating inflammatory bowel disease. No results have been published.
- Small pilot studies and case reports have appeared since, but nothing resembling a randomized, placebo-controlled trial.
So the honest summary is: BPC-157 looks good in rats, and we do not yet know if it works in people. Plenty of compounds that healed rats beautifully failed in human trials. That is why it remains a research compound.
Safety: what is known and what isn’t
Animal studies have reported very low toxicity, even at high amounts, and no lethal dose has been established in rodents. That is reassuring but limited. Rodent toxicity studies are not designed to catch rare effects, long-term effects, or effects specific to human biology.
The theoretical concern most often raised is about angiogenesis. A compound that encourages new blood vessels could, in principle, also feed blood vessels to an existing tumour. There is no evidence that BPC-157 causes cancer, but there is also no long-term human data that rules out this kind of effect. We cover this question in depth in does BPC-157 cause cancer? and the side effects reported in studies and anecdotal reports in BPC-157 side effects.
The second, more practical safety issue is product quality. Because BPC-157 is unregulated, what is in a vial depends entirely on the supplier. Independent testing of grey-market peptides has found products that were underdosed, impure or contaminated. That is a bigger real-world risk than anything in the rat literature, and the reason third-party testing matters (more on that below).
Legal status in Canada, the US and sport
| Jurisdiction | Status |
|---|---|
| Canada (Health Canada) | Not an authorized drug. In April 2026 Health Canada issued a public advisory warning against injecting peptides bought online, naming unauthorized injectable products. |
| United States (FDA) | Not approved. In 2023 the FDA placed BPC-157 in Category 2 of its compounding bulk substances list, citing potential safety risks. It was removed from that category in April 2026 after its nomination was withdrawn, and in July 2026 an FDA advisory committee voted 8–6 to recommend adding it to the list of substances pharmacies may compound. The vote is non-binding: the FDA must still decide and complete rulemaking, so as of October 2026 BPC-157 is neither approved nor yet on the compounding list. |
| Sport (WADA) | Prohibited at all times since 2022, under section S0 (non-approved substances). Athletes in tested sport cannot use it. |
In practice, BPC-157 is sold in Canada as a research chemical for laboratory use, not as a drug or supplement. That is how TrueLabs sells it, and it is the only legitimate way it can be sold here.
Acetate, arginate, oral, blends: the forms explained
BPC-157 acetate vs arginate
Peptides are made as salts. Most BPC-157 is sold as the acetate salt, the standard form used in research. An arginate (“stable”) salt is marketed as more stable in liquid. Both contain the same 15-amino-acid peptide; the salt only changes handling and stability, and the evidence comparing them is mostly manufacturer claims.
Lyophilized powder vs capsules
Research-grade BPC-157 normally comes as a lyophilized (freeze-dried) powder in a sealed vial, which is the most stable way to store a peptide. Capsule products exist because animal studies tested oral delivery, but capsule quality is even harder to verify than vials. For storage, see how to store peptides and how long reconstituted BPC-157 lasts.
BPC-157 alone vs blends
BPC-157 is very often studied and sold alongside TB-500, a fragment of thymosin beta-4 involved in cell migration. The idea is that the two act on different parts of the repair process. We compare them in BPC-157 vs TB-500 and explain the combination in BPC-157 and TB-500 together. Some blends also add GHK-Cu (the “GLOW” and “KLOW” combinations); see Wolverine vs GLOW vs KLOW.
| Product | What’s in it | From |
|---|---|---|
| BPC-157 | BPC-157 alone | $22 |
| BPC-157 + TB-500 blend | The “Wolverine” pairing | $70 |
| GLOW70 | BPC-157 + TB-500 + GHK-Cu | $130 |
| KLOW80 | GLOW + KPV | $150 |
How to judge quality before you buy
Because there is no regulator checking BPC-157, the supplier’s paperwork is your only protection. Before ordering for research, check four things:
- A batch-specific certificate of analysis (COA) whose lot number matches the vial you receive, not a generic sample report.
- HPLC purity, ideally 98% or higher, with the chromatogram attached so you can see the peaks yourself.
- Mass spectrometry confirming the molecular weight is about 1,419 Da, which proves the vial contains BPC-157 and not something else.
- An independent lab did the testing, not the manufacturer testing its own product.
Our guide to reading a peptide COA walks through a real report line by line, and how to spot fake peptides covers the red flags. You can see TrueLabs reports in the COA library. Pricing across Canada is covered in buying BPC-157 in Canada.
FAQ
Tap a question to reveal the answer.
What does BPC-157 stand for?
Body Protection Compound 157. It is a 15-amino-acid fragment of a protective protein first described in human gastric juice by researchers at the University of Zagreb.
Is BPC-157 a steroid or a hormone?
Neither. It is a short peptide, a chain of amino acids. It does not act on androgen receptors and it is not a hormone like growth hormone or testosterone.
Is BPC-157 natural?
Its sequence is copied from a fragment of a natural human protein, but the BPC-157 sold for research is made synthetically in a lab, using standard peptide synthesis.
Did the FDA approve BPC-157 in 2026?
No. In July 2026 an FDA advisory committee narrowly voted to recommend allowing US pharmacies to compound BPC-157 with a prescription. That vote is non-binding, is not a drug approval, and still requires an FDA decision and rulemaking.
Is BPC-157 approved in Canada?
No. It is not an authorized drug in Canada. It is sold only as a research chemical for laboratory use, and Health Canada has warned the public against injecting peptides bought online.
Has BPC-157 been tested in humans?
Barely. Published human data consist of a small retrospective knee-pain report, case reports and pilot work. A phase I safety trial was registered in 2015 but no results were published. There are no large randomized controlled trials.
Why is BPC-157 banned in sport?
WADA added it to its prohibited list in 2022 under S0, the category for substances not approved for human use by any health authority. It is banned in and out of competition.
What is the difference between BPC-157 and TB-500?
BPC-157 is a 15-amino-acid gastric peptide studied mainly for blood-vessel growth and fibroblast activity. TB-500 is a fragment of thymosin beta-4, studied mainly for cell migration and actin regulation. They are often researched together because they appear to act on different parts of tissue repair.
How should BPC-157 be stored?
As a lyophilized powder, sealed and frozen at −20 °C for long-term storage, or refrigerated for shorter periods. Once reconstituted, it should be refrigerated and used within weeks, not months.
Related reading
- BPC-157 side effects
- Does BPC-157 cause cancer?
- BPC-157 vs TB-500
- Tendonitis treatment in Canada: what works
- Buy BPC-157 in Canada
References
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHS. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–780. PubMed
- Chang CH, Tsai WC, Hsu YH, Pang JHS. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066–19077. PubMed
- Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med. 2017;95(3):323–333. PubMed
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153–159. PubMed
- Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021;27(4):8–13. PubMed
- ABC News. FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list. July 23, 2026. ABC News
- World Anti-Doping Agency. The Prohibited List. WADA
- Health Canada. Think twice before injecting peptides bought online. Public advisory, April 9, 2026. Health Canada
All TrueLabs products are sold for in vitro and laboratory research use only. They are not intended for human or veterinary use, and nothing on this page is medical advice.